Directory

>

Drew Fromkin

avatar

Drew Fromkin

Chief Executive Officer | Roivant Sciences

Belmar, New Jersey, United States

View contact details (it's free)

Drew Fromkin

Summary

Drew Fromkin is a seasoned executive with extensive leadership experience in the biotechnology and healthcare sectors. He has a proven track record of driving growth and creating shareholder value, notably leading Clinical Data, Inc. to a successful acquisition for $1.2 billion. With a strong background in corporate development, strategic partnerships, and product marketing, Drew has held key positions in both public and private companies, including as CEO of Tarveda Therapeutics and Proteovant Therapeutics. His expertise spans across M&A, business development, and team leadership, making him a well-rounded professional in the life sciences industry. Drew is also actively involved in board governance, serving as Chair of the compensation committee at Immunovant. His educational foundation in biology from Brandeis University complements his hands-on experience in transforming organizations and advancing innovative healthcare solutions.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Leadership Development

Emerging Technologies

Innovation

Organisational experience

Startup Experience

Corporate Experience

Consulting Experience

Drew Fromkin

Work Experience

💼

Chief Executive Officer at

Pulmovant, Inc.

July 2023 - Present

company logo

Vant Portfolio Operating Partner (Roivant Sciences) at

Roivant Sciences

January 2021 - Present

company logo

Director, Board Member at

Immunovant

October 2019 - Present

company logo

Chief Executive Officer, Protoevant Therapeutics at

Roivant Sciences

January 2021 - April 2023

company logo

President and Chief Executive Officer, Chairman at

Tarveda Therapeutics, Inc

March 2015 - September 2020

company logo

Business Consultant and Director at

Ajf Consulting

August 2012 - March 2015

company logo

President, CEO and Director at

Clinical Data

May 2006 - May 2011

company logo

Executive Vice President at

Clinical Data

October 2005 - May 2006

company logo

Consultant - Strategic Business Development at

Aetna Inc.

May 2004 - March 2005

💼

President and CEO at

DoctorQuality, Inc.

October 2002 - December 2003

💼

President and CEO at

Endo Surgical Devices Inc

January 2001 - August 2002

company logo

Vice President - Business Development (Corp. Dev. Function) at

Merck

January 1993 - January 2000

💼

Director Marketing(HIT)/GM (Subsidiary) at

Health Information Technologies, Inc.

January 1988 - January 1993

Logos provided by Logo.dev

Drew Fromkin

Education

Brandeis University, Ba

January 1984 - January 1988

Frequently Asked Questions about Drew Fromkin

What is Drew Fromkin email address?

Drew Fromkin's primary email address is ********@tarveda.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Drew Fromkin work for?

Drew Fromkin is a Chief Executive Officer at Roivant Sciences.

Where Drew Fromkin graduated from?

Drew Fromkin holds a degree in Biology from Brandeis University.

How can I directly contact Drew Fromkin?

To contact Drew Fromkin directly, you can use the email address ********@tarveda.com. Complete contact information is available upon registration with Muraena.

Who is Drew Fromkin?

Drew Fromkin is a seasoned executive with extensive leadership experience in the biotechnology and healthcare sectors. He has a proven track record of driving growth and creating shareholder value, notably leading Clinical Data, Inc. to a successful acquisition for $1.2 billion. With a strong background in corporate development, strategic partnerships, and product marketing, Drew has held key positions in both public and private companies, including as CEO of Tarveda Therapeutics and Proteovant Therapeutics. His expertise spans across M&A, business development, and team leadership, making him a well-rounded professional in the life sciences industry. Drew is also actively involved in board governance, serving as Chair of the compensation committee at Immunovant. His educational foundation in biology from Brandeis University complements his hands-on experience in transforming organizations and advancing innovative healthcare solutions.

Drew`s contact details

mail

********@tarveda.com

********@roivant.com

Colleagues

avatar
Srini Ramanathan

Chief Development Officer

avatar
Paul Davis

Chief Communications Officer

avatar
Richard Pulik

Chief Financial Officer

avatar
Sudhir Penugonda

Executive Director

avatar
Stephanie Lee Griffin

VP, Special Projects, Office of CEO

avatar
Shingai Majuru

Vice President, Head of CMC, Small Molecule Development

Eric Valeur

VP, Research

Keith Haan

Senior Vice President, Investments

avatar
Daniel Patterson

Vice President, Head of CMC, Biologics and Gene Therapies

View Contact details (it's free)
Request Profile Removal